Arch Therapeutics, Inc. announced that the Company's first commercial product, AC5®? Advanced Wound System ("AC5"), will be featured at the 2023 Symposium on Advanced Wound Care Fall Meeting ("SAWC Fall"), which takes place at Caesars Palace, Las Vegas, from November 2-5, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.96 USD | +7.80% |
|
-11.93% | -86.74% |
12/06 | Arch Therapeutics, Inc. announced that it has received $0.15 million in funding | CI |
15/05 | Arch Therapeutics, Inc. announced that it has received $1.85 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-86.74% | 4.27M | |
+13.71% | 130B | |
-9.40% | 10.77B | |
-15.31% | 7.37B | |
+46.76% | 5.87B | |
-32.21% | 4.1B | |
+8.24% | 3.44B | |
-19.53% | 2.47B | |
-17.06% | 1.94B | |
-22.28% | 1.72B |
- Stock Market
- Equities
- ARTH Stock
- News Arch Therapeutics, Inc.
- Arch Therapeutics, Inc. to Present AC5®? Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)